PT - JOURNAL ARTICLE AU - YUSAKU HORI AU - KEN ITO AU - SHUSEI HAMAMICHI AU - YOICHI OZAWA AU - JUNJI MATSUI AU - IZUMI O. UMEDA AU - HIROFUMI FUJII TI - Functional Characterization of VEGF- and FGF-induced Tumor Blood Vessel Models in Human Cancer Xenografts DP - 2017 Dec 01 TA - Anticancer Research PG - 6629--6638 VI - 37 IP - 12 4099 - http://ar.iiarjournals.org/content/37/12/6629.short 4100 - http://ar.iiarjournals.org/content/37/12/6629.full SO - Anticancer Res2017 Dec 01; 37 AB - Background/Aim: Tumor angiogenesis induced by vascular endothelial growth factor (VEGF) and/or fibroblast growth factor (FGF) plays an important role in tumor growth, metastasis, and drug resistance. However, the characteristics of tumor vessels derived from these angiogenic factors have not been fully explored. Materials and Methods: To functionally examine tumor vessels, we developed in vivo VEGF- and FGF-induced tumor blood vessel models. We performed immunohistochemistry and Hoechst perfusion assay to elucidate histopathological differences between the derived tumor vessels. To kinetically understand tumor perfusion, we employed radiolabeled PEGylated liposomes. Results: While tumor vessel density was substantially increased by enhanced expression levels of VEGF and FGF, permeability of VEGF-driven tumor vessels was significantly higher than that of FGF-driven ones, the latter demonstrating an increased number of pericyte-covered vessels. Accordingly, we observed an increased tumor retention of the PEGylated liposomes in the VEGF-driven tumor. Conclusion: Our in vivo models of tumor vessel demonstrate the frequency of pericyte coverage and tumor perfusion levels as major functional differences between VEGF- and FGF-driven tumor vessels.